Xcout IntelUNICORN AIM VCT PLC competitors & alternatives
The 12 closest competitors and alternatives to UNICORN AIM VCT PLC among investment management companies — ranked by similarity to what UNICORN AIM VCT PLC actually does, not by market-cap band.
Subscribe to see UNICORN AIM VCT PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About UNICORN AIM VCT PLC
Unicorn AIM VCT plc operates as a venture capital trust, primarily focused on making early-stage and growth-oriented investments. It diversifies its capital across a broad spectrum of industries, including software development, IT services, the pharmaceutical sector, and biotechnology.
UNICORN AIM VCT PLC at a glance
UNICORN AIM VCT PLC is an investment management company headquartered in London, United Kingdom, founded in 2001. It is publicly listed (UAV) with a market capitalisation of $190.8M. Xcout tracks 1 named person at UNICORN AIM VCT PLC, including Julian Bartlett (Chairman of the Audit Committee).
UNICORN AIM VCT PLC leadership
- Julian BartlettChairman of the Audit Committee
Top 12 UNICORN AIM VCT PLC competitors
Ranked by semantic similarity — how close each company is to UNICORN AIM VCT PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Investment
Vault Ventures Plc is a UK-based public limited venture capital firm founded in August 2018 and listed on AQUIS. The firm specializes in early-stage investments with a focus on blockchain and Web3 infrastructure, fintech, and artificial intelligence opportunities.
Similar investment management company
The Edinburgh Investment Trust seeks to grow capital and dividends by investing in UK companies. It serves investors through discretionary wealth managers, independent financial advisers, and execution-only investment platforms.
Investment Holdings
Caledonian Holdings PLC is a venture capital and private equity firm specializing in early, mid, late, growth capital, and special situation investments. The firm focuses on disruptive technology businesses; pre-IPO technology investments; financial services and associated markets; fintech, asset management, insurance, banking, and also invests in hi-tech engineering solutions. The firm prefers to have a mixture of early stage, pre-liquidity event and liquid investments. The firm also prefers to invest in loan stock which is convertible (at Vela’s option) into equity shares. It invests in small and medium sized companies based in Europe and United Kingdom including the Channel Islands. The firm seeks for non-controlling stakes in its portfolio companies. The firm prefers to have a mix of private and publicly-traded investments. It was formerly known as Vela Technologies PLC and changed its name to Caledonian Holdings PLC in March 2025. Caledonian Holdings PLC was founded in 2000 and is based in Bingley, United Kingdom with an additional office in London, Greater London.
Similar investment management company
Vulcan Two Group plc is a United Kingdom-based investment company focused on acquiring businesses in the ePharmacy market. The company executes a buy-and-build strategy to consolidate the private sector and develop a regulated ePharmacy platform.
Similar investment management company
Acceler8 Ventures Plc currently operates without substantial business activities. Its primary objective is to seek out and invest in potential opportunities within diverse sectors, including gaming, media and entertainment, software and technology, industrials, and business services. Incorporated in 2021, the firm maintains its official domicile in Saint Helier, Jersey.
Investment Company
Gresham House Strategic plc operates as an investment fund, specializing in various capital injections including private investments in public equity (PIPEs), pre-initial public offering (pre-IPO) financing, growth and acquisition funding, and recovery capital. The fund directs its investments towards companies primarily within the financial services, media, information and communication technology, digital information and technology, healthcare, and life sciences industries. While its main geographic focus is on the United Kingdom and Europe, it also undertakes co-investments beyond Europe in collaboration with local venture capital firms. This fund actively seeks opportunities for follow-on investments, typically acquiring ownership stakes of between 5% and 25% in target companies, which can be paid for with cash or shares. The intended investment horizon for these holdings ranges from three to five years. It invests in both smaller public companies and private enterprises. For public company investments, the fund targets those listed on the FTSE All-Share and AIM All-Share indices that meet specific criteria: stocks trading more than 50% below their three-year price peak, an Enterprise Value to EBITDA multiple less than 7 times, gearing above 75%, a Return on Capital Employed (ROCE) exceeding 10%, and a Free Cash Flow (FCF) Yield greater than 10%. In the private sector, investments encompass peer-to-peer (P2P) opportunities, various forms of equity and equity-related instruments, preferred equity, and preferred quasi-equity positions, including both convertible and non-convertible debt, as well as mezzanine financing. Excluding cash, the fund's portfolio is characterized by a weighted average Enterprise Value to EBITDA ratio surpassing 5 times and, as per broker forecasts, achieved over 10% growth in 2017. Ultimately, Gresham House Strategic plc aims for a long-term net Internal Rate of Return (IRR) of 15%.
Similar investment management company
Chrysalis Investments, formerly known as Merian Chrysalis, is a British investment trust headquartered in London that invests in a portfolio of UK and European growth companies.
Investment Holdings
Operating as a real estate investment company, Dukemount Capital Plc was formerly identified as Black Eagle Capital PLC. Prior to its current business model, the entity functioned as a venture capital firm, primarily concentrating on initial seed investments. The company's main base of operations is in London, United Kingdom.
Investment Company
Ashington Innovation PLC primarily seeks to acquire businesses or companies, with a particular emphasis on the financial technology and deep technology sectors. This London, UK-based firm was established in 2020.
Similar investment management company
Highway Capital PLC, a company operating out of the United Kingdom, is dedicated to either purchasing or making strategic investments in businesses. Its core focus is on identifying undervalued entities that are underpinned by substantial assets or offer attractive prospects in sectors where entry is notably difficult.
Not Applic
Thorney Technologies Ltd is an Australian-based investment firm with a core business of deploying capital into global technology ventures. It supports both publicly listed and privately held companies throughout all stages of their development cycle. The firm actively seeks out early-stage enterprises that are pioneering innovative and disruptive technologies or business models. Its diversified investment portfolio spans numerous technology segments, including financial technology, e-commerce, education, agricultural tech, medical advancements, telecommunications, robotics, and artificial intelligence. Thorney Management Services Pty Ltd is responsible for the management of the company.
Not Applic
BTC Health Limited operates as a Pooled Development Fund, overseen by LHC Capital Partners Pty Ltd. The fund strategically deploys capital across various corporate development stages, from initial seed and startup funding to early, mid, and late-stage venture growth, and into emerging and established growth companies. Its investment focus lies primarily within the healthcare and biotechnology industries, with a specific emphasis on groundbreaking areas such as post-genomics, which encompasses functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. It also targets stem cell biology, particularly stem cell therapies. Other key areas of interest include convergent technologies, like biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics; silicon biology, involving structure-based drug design, virtual screening, computational library design, and in silico ADME/tox; and nanomedicine. The fund exclusively supports businesses located in Australia, investing in both publicly traded and privately held enterprises.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of UNICORN AIM VCT PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for UNICORN AIM VCT PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →